Cardiovascular
Read More about this categoryShow Less
Cardiovascular
The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment.
Research Areas
- Acute Phase Reactants(15)
- Angina(14)
- Arrhythmia(82)
- Atherosclerosis(88)
- Chronic Kidney Disease(18)
- Coagulation & Hemostasis(124)
- Coronary Artery Disease(7)
- Diabetic Nephropathy(8)
- Endothelium(33)
- Erythrocytes & Hemoglobin(49)
- Heart Failure(33)
- Hypertension(162)
- Hypotension(24)
- Lipoproteins(61)
- Myocardial Contractility(33)
- Myocardial Hypertrophy(21)
- Myocardial Infarction(61)
- Others(1)
- Serum Proteins(11)
- Smooth Muscle Cells(36)
- Storage & Transport(6)
- Stroke(48)
- Thrombosis(52)
- Vasoconstriction(59)
- Vasodilation(141)
- Cardiogenesis
- Cardiomyopathy(5)
- Cholesterol Metabolism(44)
Products Related to Cardiovascular(821)
- GC9110917β-Estradiol 3-O-Sulfate (sodium salt)CAS: 4999-79-5Purity: >98.00%
Ein inaktives Stoffwechselprodukt von 17β-Östradiol.
- GC91229DXR Inhibitor 11a (free acid)CAS: 2260608-07-7Purity: >98.00%
Ein Inhibitor von P. falciparum DXR
- GC91424S1PL-IN-31CAS: 1538574-95-6Purity: >98.00%
S1PL-IN-31 ist ein Hemmstoff der Sphingosin-1-Phosphat (S1P) Lyase (IC50 = 210 nM).
- GC91472Tat-Gap 19 (trifluoroacetate salt)Purity: >95.00%
Tat-Gap 19 ist ein Peptid-Inhibitor von Connexin43 (Cx43) Hämichannels.
- GC91493Semaglutide Side ChainCAS: 1118767-16-0Purity: >98.00%
Semaglutide side chain is a synthetic intermediate.
- GC91497EB 47 (hydrochloride)CAS: 1190332-25-2Purity: >98.00%
EB 47 is an inhibitor of poly(ADP-ribose) polymerase 1 (PARP1; IC50 = 45 nM) and a dual site inhibitor of tankyrase 2 (TNKS2; IC50 = 45 nM).
- GC91544Fmoc-L-Lys[Oct-(OtBu)-Glu-(OtBu)-AEEA-AEEA]-OHCAS: 1662688-20-1Purity: >99.50%
Fmoc-L-Lys[Oct-(OtBu)-Glu-(OtBu)-AEEA-AEEA]-OH is a building block in the synthesis of the glucagon-like peptide 1 receptor (GLP-1R) agonist semaglutide .
- GC91639Ferrous trisglycinateCAS: 34369-82-9Purity: >95.00%
Ferrous trisglycinate is an iron amino acid chelate.
- GC916804-Acetamido AntipyrineCAS: 83-15-8Purity: >95.00%
4-Acetamido antipyrine (4-AAAP) is an active metabolite of the non-opioid analgesic and antipyretic prodrug metamizole .
- GC91889L-Tyrosine (sodium salt hydrate)Purity: >98.00%
L-Tyrosine (sodium salt hydrate) ist eine bedingt essentielle Aminosäure.
- GC91898BI SF3 (hydrochloride)CAS: 1801257-24-8Purity: >95.00%
BI SF3 (hydrochloride) ist ein synthetisches Zwischenprodukt.
- GC91910Ferroptosis Inhibitor D1Purity: >98.00%
Ferroptosis Inhibitor D1 ist ein Radikalfänger und ein Ferroptosehemmer.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC91053 | RM 133-3 | 2941228-90-4 | >95.00% | |
Ein ionisierbares kationisches Lipid. | ||||
| GC91065 | (±)13,14-EDT | 355016-19-2 | >98.00% | |
Ein Metabolit von Adreninsäure. | ||||
| GC91067 | (±)16,17-EDT | 351533-79-4 | >98.00% | |
Ein Metabolit von Adreninsäure. | ||||
| GC91083 | Tiopronin-Cysteine Disulfide | 77591-18-5 | >95.00% | |
Ein Metabolit von Tiopronin | ||||
| GC91100 | UCL-TRO-1938 | 2919575-27-0 | >98.00% | |
Ein allosterischer PI3Kα-Aktivator | ||||
| GC91109 | 17β-Estradiol 3-O-Sulfate (sodium salt) | 4999-79-5 | >98.00% | |
Ein inaktives Stoffwechselprodukt von 17β-Östradiol. | ||||
| GC91136 | XY-4 | 474329-47-0 | >95.00% | |
Ein Agonist von PPARγ | ||||
| GC91141 | DXR Inhibitor 11a (sodium salt) | - | >98.00% | |
Ein Inhibitor von P. falciparum DXR | ||||
| GC91223 | Brain Natriuretic Peptide-32 (rat) (acetate) | - | >98.00% | |
Ein natriuretisches Peptid | ||||
| GC91229 | DXR Inhibitor 11a (free acid) | 2260608-07-7 | >98.00% | |
Ein Inhibitor von P. falciparum DXR | ||||
| GC91410 | RA-2 | 1867107-62-7 | >95.00% | |
RA-2 ist ein Inhibitor des Kalzium-aktivierten kleinen Leitfähigkeits-Kaliumkanals 2.3 (KCa2.3/SK3) und des Kalzium-aktivierten intermediären Leitfähigkeits-Kaliumkanals 3.1 (KCa3.1/IK1) (IC50s = 2 bzw. 17 nM). | ||||
| GC91424 | S1PL-IN-31 | 1538574-95-6 | >98.00% | |
S1PL-IN-31 ist ein Hemmstoff der Sphingosin-1-Phosphat (S1P) Lyase (IC50 = 210 nM). | ||||
| GC91472 | Tat-Gap 19 (trifluoroacetate salt) | - | >95.00% | |
Tat-Gap 19 ist ein Peptid-Inhibitor von Connexin43 (Cx43) Hämichannels. | ||||
| GC91493 | Semaglutide Side Chain | 1118767-16-0 | >98.00% | |
Semaglutide side chain is a synthetic intermediate. | ||||
| GC91497 | EB 47 (hydrochloride) | 1190332-25-2 | >98.00% | |
EB 47 is an inhibitor of poly(ADP-ribose) polymerase 1 (PARP1; IC50 = 45 nM) and a dual site inhibitor of tankyrase 2 (TNKS2; IC50 = 45 nM). | ||||
| GC91544 | Fmoc-L-Lys[Oct-(OtBu)-Glu-(OtBu)-AEEA-AEEA]-OH | 1662688-20-1 | >99.50% | |
Fmoc-L-Lys[Oct-(OtBu)-Glu-(OtBu)-AEEA-AEEA]-OH is a building block in the synthesis of the glucagon-like peptide 1 receptor (GLP-1R) agonist semaglutide . | ||||
| GC91615 | AZD 5462 | 2787501-83-9 | >98.00% | |
AZD 5462 is an agonist of relaxin family peptide receptor 1 (RXFP1). | ||||
| GC91639 | Ferrous trisglycinate | 34369-82-9 | >95.00% | |
Ferrous trisglycinate is an iron amino acid chelate. | ||||
| GC91680 | 4-Acetamido Antipyrine | 83-15-8 | >95.00% | |
4-Acetamido antipyrine (4-AAAP) is an active metabolite of the non-opioid analgesic and antipyretic prodrug metamizole . | ||||
| GC91889 | L-Tyrosine (sodium salt hydrate) | - | >98.00% | |
L-Tyrosine (sodium salt hydrate) ist eine bedingt essentielle Aminosäure. | ||||
| GC91898 | BI SF3 (hydrochloride) | 1801257-24-8 | >95.00% | |
BI SF3 (hydrochloride) ist ein synthetisches Zwischenprodukt. | ||||
| GC91910 | Ferroptosis Inhibitor D1 | - | >98.00% | |
Ferroptosis Inhibitor D1 ist ein Radikalfänger und ein Ferroptosehemmer. | ||||
| GC91915 | ZG-2033 | 2685739-28-8 | >98.00% | |
ZG-2033 ist ein Agonist des hypoxieinduzierbaren Faktors 2α (HIF-2α). | ||||
| GC91933 | E17241 | 1060968-92-4 | >95.00% | |
E17241 ist ein Induktor der Expression von ABCA1, dem Gen, das ATP-bindenden Kassettentransporter 1 kodiert; Unterfamilie A (ABCA1). | ||||